GELESIS HOLDINGS, INC.

Gelesis Holdings, Inc., filing under ticker CPSR, submitted a Form 10-Q with the SEC on August 16, 2021, reflecting its status as Capstar Special Purpose Acquisition Corp., a blank-check company that completed its initial public offering in 2021. Backed by sponsor Capstar, the vehicle was formed to pursue opportunities in the healthcare and life sciences sector. By the time of this quarterly filing, the SPAC had announced a planned business combination with Gelesis, a biotech company focused on hydrogel-based weight management treatments, positioning the resulting post-merger entity in the medical device and consumer health space. For complete deal timelines, status updates, and analytics on CPSR and hundreds of other SPACs, sign up for full data access at SpacDesk.